Science with a strong commercial focus

Opsona Therapeutics has assembled an experienced management team and a dedicated team of project managers and scientists to execute our strategy.

Our Board of Directors have a wealth of experience in the global pharmaceutical industry and include biotechnology veterans, financiers and leading academics. The make-up of the board ensures that our company is underpinned by solid scientific foundations coupled with a strong commercial focus.


The academic founders of our company include leading immunologists - Professor Luke O'Neill and Professor Kingston Mills and leading translational gastroenterologist Professor Dermot Kelleher.


Find out more about our management team.

Read more about our  Board of Directors.